Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.

Chongxian HouYukitomo IshiHiroaki MotegiMichinari OkamotoYafei OuJiawei ChenShigeru Yamaguchi

Published in: Journal of neuro-oncology (2019)

The present study suggests that overexpression of CD44 is associated with a poor prognosis for grade II/III glioma patients. Moreover, our findings suggest that CD44 could serve as a prognostic biomarker in grade II/III glioma patients.

Keyphrases

poor prognosis
long non coding rna
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
cell proliferation
prognostic factors
nk cells